T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease

Conditions:   NAFLD;   Heart Failure;   Valvular Disease;   Coronary Disease Intervention:   Diagnostic Test: T1 mapping on Cardiovascular Magnetic Resonance Studies Sponsor:   Dr. Andreas Kammerlander Not yet recruiting

Source: ClinicalTrials.gov - January 7, 2020 Category: Research Source Type: clinical trials